等待开盘 02-07 09:30:00 美东时间
0.000
NaN.00%
Johnson & Johnson reported encouraging Phase 2 results for its experimental lupus drug nipocalimab in patients with SLE.
01-07 02:42
Factorial Inc. ("Factorial"), a leader in solid-state battery technology, and Cartesian Growth Corporation III ("Cartesian III"), a special purpose acquisition company, announced today that they have entered into a
2025-12-18 21:03
Cartesian Therapeutics shared initial data from Phase 2 trial of Descartes-08, showing potential for treating systemic lupus erythematosus.
2025-11-15 02:02